Prevalence of Asymptomatic Rupture in SILIMED Breast Implants
NCT ID: NCT02206282
Last Updated: 2014-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
390 participants
OBSERVATIONAL
2006-08-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Analysis of Adverse Events and Satisfaction Outcomes of Women Who Underwent Primary and Secondary Breast Augmentation Using Silimed® Breast Implants
NCT03356132
Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants
NCT00691327
Sientra Sponsored Silimed Gel-Filled Breast Implant Core Clinical Study
NCT00905645
Observational Study to Assess Long-Term Follow-Up of Breast Augmentation Subjects
NCT01076686
Do Closed Suction Drains Affect the Complications Rate of Breast Reconstruction With Silicone Prosthesis?
NCT00973544
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject implanted with the original Silimed gel-filled implant.
Exclusion Criteria
* Metal implant
* Battery activated stimulator
* Pregnancy
* Tattoos
* Body weight \>300 pounds
* History of metal fragments in the eye
* Any other contraindication to MR exam.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Silimed Industria de Implantes Ltda
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wanda Elizabeth Massiere Correa, MD
Role: PRINCIPAL_INVESTIGATOR
Insituto Ivo Pitanguy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IMR-LT-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.